Clinical endocrinology of human leptin

被引:74
作者
Van Gaal L.F. [1 ]
Wauters M.A. [1 ]
Mertens I.L. [1 ]
Considine R.V. [2 ]
De Leeuw I.H. [1 ]
机构
[1] Department of Endocrinology, Metabolism and Clinical Nutrition, University Hospital Antwerp, Edegem, Antwerp
[2] Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN
关键词
Body fat distribution; Endocrinology; Hormones; Leptin;
D O I
10.1038/sj.ijo.0800792
中图分类号
学科分类号
摘要
Since the discovery of leptin, a boom of scientific knowledge became available about the OB-protein gene and its role and significance in weight regulation. Both from animal and human research data, serum leptin can probably be considered as one of the best biological markers to reflect total body fat, and this finding is true over a wide range of body mass indexes (BMIs) and in different pathologies: in normal weight, anorexic and obese subjects; in non insulin-dependent diabetes mellitus (NIDDM) patients, PCO women, Prader-Willi children and subjects with hypogonadism and growth hormone deficiency.Gender differences clearly exist, probably related to sex hormone differences, and from fat distribution studies it could be shown that subcutaneous fat is much more related to serum leptin concentrations than visceral fat: also leptin messenger-RNA (m-RNA) expression is significantly higher in subcutaneous fat from human obese subjects.Leptin is not only correlated to a series of endocrine parameters such as insulin, insulin-like growth factor, (IGF) and SHBG, it seems involved as a mediator in some endocrine mechanisms (onset of puberty, insulin secretion, etc) as well.Weight loss will reduce human leptin concentrations, whereas the administration of human recombinant leptin seems to show only limited effects. © 1999 Stockton Press. All rights reserved.
引用
收藏
页码:29 / 36
页数:7
相关论文
共 55 条
[21]  
Friedman J.M., Role of leptin and its receptors in the control of body weight, Leptin: The Voice of Adipose Tissue, pp. 3-22, (1997)
[22]  
Ravussin E., Pratley R.E., Maffei M., Wang H., Friedman J., Bennett P.H., Bogardus C., Relatively low plasma leptin concentrations precede weight gain in pima indians, Nat Med, 3, pp. 238-240, (1997)
[23]  
Montague C.T., Faroogi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammaed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins A.H., O'Rahilly S., Congenital leptin deficiency is associated with severe early-onset obesity in humans, Nature, 387, pp. 903-908, (1997)
[24]  
Van Gaal L., Vansant G., De Leeuw I., Upper body adiposity and the risk for atherosclerosis, J am Coll Nutr, 8, pp. 504-514, (1989)
[25]  
Weigle D.S., Ganter S.L., Kuijper J.L., Leonetti D.L., Boyko E.J., Fujimoto W.Y., Effect of regional fat distribution and prader-willi syndrome on plasma leptin levels, J Clin Endocrinol Metab, 82, pp. 566-570, (1997)
[26]  
Lunnqvist F., Wennlund A., Arner P., Relationship between circulating leptin and peripheral fat distribution in obese subjects, Int J Obes, 21, pp. 255-260, (1997)
[27]  
Dua A., Hennes M.I., Hoffmann R.G., Maas D.L., Krakower G.R., Sonnenberg G.E., Kissebah A.H., Leptin: A significant indicator of total body fat but not of visceral fat and insulin insensitivity in african-american women, Diabetes, 45, pp. 1635-1637, (1996)
[28]  
Lefebvre A.-M., Laville M., Vega N., Riou J.P., Van Gaal L., Auwerx J., Vidal H., Depot-specific differences in adipose tissue gene expression in lean and obese subjects, Diabetes, 47, pp. 98-103, (1998)
[29]  
Montague C.T., Prins J.B., Sanders L., Digby J.E., O'Rahilly S., Depot-and sex-specific differences in human leptin mrna expression. Implications for the control of regional fat distribution, Diabetes, 46, pp. 342-347, (1997)
[30]  
Considine R.V., Considine E.L., Williams C.J., Nyce M.R., Magosin S.A., Bauer T.L., Rosato E.L., Colberg J., Caro J.F., Evidence against either a premature stop codon or the absence of obese gene mrna in human obesity, J Clin Invest, 95, pp. 2986-2988, (1995)